Toward understanding and exploiting tumor heterogeneity
Ash A. Alizadeh(California Institute for Regenerative Medicine), Jessica Zucman‐Rossi(Inserm), Jean C. Zenklusen(National Cancer Institute), Manel Esteller(Institució Catalana de Recerca i Estudis Avançats), Kornélia Polyák(Dana-Farber Cancer Institute), Michael Doherty(University of Nottingham), Charles Swanton(The Francis Crick Institute), Markus Elsner(University of Cambridge), Roel G.W. Verhaak(University of New Haven), Andrea Califano(Columbia University Irving Medical Center), Rebecca C. Fitzgerald(Cancer Research UK), Victoria Aranda(Stanford University), Christoph Bock(Austrian Academy of Sciences), Christine Borowski, Nicholas E. Navin(The University of Texas MD Anderson Cancer Center), Alberto Bardelli(IFOM), Charles W.M. Roberts(Harvard University), Jan O. Korbel(European Bioinformatics Institute), Dana Pe’er(Memorial Sloan Kettering Cancer Center), Alexandra Snyder(MedStar Washington Hospital Center), Cédric Blanpain(Université Libre de Bruxelles), Christopher E. Mason(Cornell University), Carlos Caldas(University of Cambridge), Johannes Zuber(Research Institute of Molecular Pathology), Lillian L. Siu(University Health Network), Peter Lichter(German Cancer Research Center), Hannah Stower
Cited by 770
Related Papers
A global reference for human genetic variation
|Nature|2015|19.9k
Inferring tumour purity and stromal and immune cell admixture from expression data
|Nature Communications|2013|10.7k
Signatures of mutational processes in human cancer
|Nature|2013|10.1k